Neonatal Abstinence Syndrome (NAS) /Neonatal Opioid Withdrawal Syndrome (NOWS), Clinical Pathway, Inpatient
Neonatal Abstinence Syndrome (NAS) /Neonatal Opioid Withdrawal Syndrome (NOWS), Clinical Pathway, Inpatient
Modified Finnegan Scoring: Pharmacologic Treatment Recommendations
SCHEDULED Pharmacologic Treatment Recommendations
Scores should be verified by two evaluators prior to initiation of medication.
Score | Morphine Initial Dose |
Route | Comments |
---|---|---|---|
|
|
|
|
|
|
PO | |
|
Modified Finnegan: Second Line Medications
Consider adding if > 1 mg/kg/day of morphine is required for symptom control.
Consider starting phenobarbital earlier if significant neurologic symptoms (tremors, poor sleep patterns), or unable to wean morphine in spite of maximized non-pharmacologic treatment.
Medication | Initial Dose | Route | Maintenance Dose |
---|---|---|---|
Phenobarbital |
|
|
|
Clonidine Alternate 2nd line |
|
|
|